Page last updated: 2024-09-03

imatinib mesylate and Allergy, Drug

imatinib mesylate has been researched along with Allergy, Drug in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (75.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beltramini, S; Bergamaschi, M; Bignardi, D; Lappas, K; Mina, F; Minale, P; Penza, E	1
Buranapraditkun, S; Klaewsongkram, J; Mongkolpathumrat, P; Sodsai, P; Thantiworasit, P	1
Dippel, E; Hildenbrand, R; Hochhaus, A; Schadendorf, D; Ugurel, S	1
Alvarez-Larrán, A; Camós, M; Cervantes, F; Conde, E; García-Conde, J; Hernández-Boluda, JC; López-Jiménez, J; Odriozola, J; Osorio, S; Steegmann, JL; Villalón, L	1
Bullorsky, E; Ricchione, D; Saxton, R; Schamun, A; Stemmelin, G	1
Cornetta, K; Cripe, LD; Fausel, C; Nelson, RP; Ramanuja, S; Ward, KE	1
Artoni, A; Colombi, M; Deliliers, GL; Iurlo, A; Radaelli, F; Reda, G; Ripamonti, F; Vener, C	1
Contentin, N; Courville, P; Duval-Modeste, AB; Goldman, J; Joly, P; Lambert, A; Musette, P	1

Trials

1 trial(s) available for imatinib mesylate and Allergy, Drug

Article	Year
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients. Haematologica, 2003, Volume: 88, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Aged; Benzamides; Disease-Free Survival; Drug Administration Schedule; Drug Hypersensitivity; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Piperazines; Prognosis; Pyrimidines; Spain; Treatment Outcome	2003

Article

Year

Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients.

Haematologica, 2003, Volume: 88, Issue:10

Topics: Administration, Oral; Adolescent; Adult; Aged; Benzamides; Disease-Free Survival; Drug Administration Schedule; Drug Hypersensitivity; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Middle Aged; Piperazines; Prognosis; Pyrimidines; Spain; Treatment Outcome

2003

Other Studies

7 other study(ies) available for imatinib mesylate and Allergy, Drug

Article	Year
Hypersensitivity to Imatinib: Successful Desensitization in a Skin Test-Positive Patient. Journal of investigational allergology & clinical immunology, 2018, Volume: 28, Issue:6 Topics: Aged, 80 and over; Desensitization, Immunologic; Drug Hypersensitivity; Humans; Imatinib Mesylate; Male; Skin Tests	2018
Slow desensitization of imatinib-induced nonimmediate reactions and dynamic changes of drug-specific CD4 Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2016, Volume: 117, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Desensitization, Immunologic; Drug Hypersensitivity; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Prednisolone; Protein Kinase Inhibitors; T-Lymphocyte Subsets	2016
Dose-dependent severe cutaneous reactions to imatinib. British journal of cancer, 2003, Apr-22, Volume: 88, Issue:8 Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Drug Hypersensitivity; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Skin Diseases	2003
Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy. Blood, 2005, Apr-01, Volume: 105, Issue:7 Topics: Administration, Topical; Antineoplastic Agents; Benzamides; Cyclosporine; Drug Hypersensitivity; Female; Humans; Imatinib Mesylate; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Piperazines; Pyrimidines	2005
Desensitization to imatinib in patients with leukemia. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006, Volume: 97, Issue:2 Topics: Administration, Oral; Adolescent; Aged; Antineoplastic Agents; Benzamides; Desensitization, Immunologic; Drug Hypersensitivity; Exanthema; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines	2006
Conjunctival hemorrhagic events associated with imatinib mesylate. International journal of hematology, 2007, Volume: 86, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Benzamides; Conjunctival Diseases; Drug Hypersensitivity; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Hemorrhage; Humans; Imatinib Mesylate; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines	2007
[Imatinib-induced DRESS]. Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Drug Hypersensitivity; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Skin; Skin Diseases	2008